» Articles » PMID: 30994733

Sepsis: Evolving Concepts and Challenges

Overview
Date 2019 Apr 18
PMID 30994733
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis remains a major cause of morbidity and mortality worldwide, with increased burden in low- and middle-resource settings. The role of the inflammatory response in the pathogenesis of the syndrome has supported the modern concept of sepsis. Nevertheless, a definition of sepsis and the criteria for its recognition is a continuous process, which reflects the growing knowledge of its mechanisms and the success and failure of diagnostic and therapeutic interventions. Here we review the evolving concepts of sepsis, from the "systemic inflammatory response syndrome triggered by infection" (Sepsis-1) to "a severe, potentially fatal, organic dysfunction caused by an inadequate or dysregulated host response to infection" (Sepsis-3). We focused in the pathophysiology behind the concept and the criteria for recognition and diagnosis of sepsis. A major challenge in evaluating the host response in sepsis is to characterize what is protective and what is harmful, and we discuss that, at least in part, the apparent dysregulated host response may be an effort to adapt to a hostile environment. The new criteria for recognition and diagnosis of sepsis were derived from robust databases, restricted, however, to developed countries. Since then, the criteria have been supported in different clinical settings and in different economic and epidemiological contexts, but still raise discussion regarding their use for the identification versus the prognostication of the septic patient. Clinicians should not be restricted to definition criteria when evaluating patients with infection and should wisely use the broad array of information obtained by rigorous clinical observation.

Citing Articles

Dynamic Immune Indicator Changes as Predictors of ARDS in ICU Patients with Sepsis: A Retrospective Study.

Lu X, Chen Y, Zhang G, Zeng X, Lai L, Qu C Int J Gen Med. 2025; 18:1163-1172.

PMID: 40051893 PMC: 11882469. DOI: 10.2147/IJGM.S501252.


Sepsis: the evolution of molecular pathogenesis concepts and clinical management.

Feng Z, Wang L, Yang J, Li T, Liao X, Kang Y MedComm (2020). 2025; 6(3):e70109.

PMID: 39991626 PMC: 11847631. DOI: 10.1002/mco2.70109.


Effect of changes trajectory of serum phosphate levels on the 28-day mortality risk in patients with sepsis: a retrospective cohort study from the MIMIC-IV database.

Zhang R, Zhou D BMC Infect Dis. 2025; 25(1):245.

PMID: 39984839 PMC: 11844063. DOI: 10.1186/s12879-025-10547-9.


TRIM11 modulates sepsis progression by promoting HOXB9 ubiquitination and inducing the NF-κB signaling pathway.

Gan J, Zhang W, Pan F, Qiu Z, Chen X Mol Biol Rep. 2025; 52(1):194.

PMID: 39903348 DOI: 10.1007/s11033-024-10212-5.


Dexmedetomidine plays a protective role in sepsis-associated myocardial injury by repressing PRMT5-mediated ferroptosis.

Wang D, Wang J, Yang L, Wang X, Huang S Toxicol Res (Camb). 2025; 14(1):tfaf010.

PMID: 39902345 PMC: 11787764. DOI: 10.1093/toxres/tfaf010.


References
1.
Trzeciak S, Dellinger R, Chansky M, Arnold R, Schorr C, Milcarek B . Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med. 2007; 33(6):970-7. DOI: 10.1007/s00134-007-0563-9. View

2.
Nucci L, Santos S, Brunialti M, Sharma N, Machado F, Assuncao M . Expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and mitochondrial oxidative phosphorylation in septic patients. PLoS One. 2017; 12(2):e0172024. PMC: 5300193. DOI: 10.1371/journal.pone.0172024. View

3.
Janeway Jr C . Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 1:1-13. DOI: 10.1101/sqb.1989.054.01.003. View

4.
Machado F, Assuncao M, Biasi Cavalcanti A, Japiassu A, de Azevedo L, Oliveira M . Getting a consensus: advantages and disadvantages of Sepsis 3 in the context of middle-income settings. Rev Bras Ter Intensiva. 2017; 28(4):361-365. PMC: 5225908. DOI: 10.5935/0103-507X.20160068. View

5.
Williams N, ONeill L . A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation. Front Immunol. 2018; 9:141. PMC: 5807345. DOI: 10.3389/fimmu.2018.00141. View